These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 20850224
1. Predictors of psychosis severity in individuals with primary stimulant addictions. Lichlyter B, Purdon S, Tibbo P. Addict Behav; 2011; 36(1-2):137-9. PubMed ID: 20850224 [Abstract] [Full Text] [Related]
3. Risk factors for experiencing psychosis during cocaine use: a preliminary report. Floyd AG, Boutros NN, Struve FA, Wolf E, Oliwa GM. J Psychiatr Res; 2006 Mar; 40(2):178-82. PubMed ID: 16048728 [Abstract] [Full Text] [Related]
4. Subjective responses to initial experience with cocaine: an exploration of the incentive-sensitization theory of drug abuse. Lambert NM, McLeod M, Schenk S. Addiction; 2006 May; 101(5):713-25. PubMed ID: 16669905 [Abstract] [Full Text] [Related]
6. Characteristics of primary amphetamine users in Sweden: a criminal justice population examined with the Addiction Severity Index. Hakansson A, Schlyter F, Berglund M. Eur Addict Res; 2009 May; 15(1):10-8. PubMed ID: 19052458 [Abstract] [Full Text] [Related]
7. Cocaine addiction as a neurological disorder: implications for treatment. Majewska MD. NIDA Res Monogr; 1996 May; 163():1-26. PubMed ID: 8809851 [Abstract] [Full Text] [Related]
8. The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment. Lejuez CW, Paulson A, Daughters SB, Bornovalova MA, Zvolensky MJ. Behav Res Ther; 2006 May; 44(5):667-77. PubMed ID: 16002042 [Abstract] [Full Text] [Related]
14. Relationship of "prodromal" symptoms with severity and type of psychopathology in the active phase of schizophrenia. Moukas G, Stathopoulou A, Gourzis P, Beratis IN, Beratis S. Compr Psychiatry; 2010 Dec; 51(1):1-7. PubMed ID: 19932819 [Abstract] [Full Text] [Related]
15. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R. Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960 [Abstract] [Full Text] [Related]
16. A 12-year follow-up study of psychiatric symptomatology among cocaine-dependent men. Herbeck DM, Hser YI, Lu AT, Stark ME, Paredes A. Addict Behav; 2006 Nov; 31(11):1974-87. PubMed ID: 16503094 [Abstract] [Full Text] [Related]
17. Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory. Tolliver BK, McRae-Clark AL, Saladin M, Price KL, Simpson AN, DeSantis SM, Baker NL, Brady KT. Am J Drug Alcohol Abuse; 2010 Mar; 36(2):106-13. PubMed ID: 20337507 [Abstract] [Full Text] [Related]
18. [Relationships between insight and medication adherence in subjects with psychosis]. Droulout T, Liraud F, Verdoux H. Encephale; 2003 Mar; 29(5):430-7. PubMed ID: 14615692 [Abstract] [Full Text] [Related]
19. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Konings M, Henquet C, Maharajh HD, Hutchinson G, Van Os J. Acta Psychiatr Scand; 2008 Sep; 118(3):209-13. PubMed ID: 18452569 [Abstract] [Full Text] [Related]
20. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH. Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725 [Abstract] [Full Text] [Related] Page: [Next] [New Search]